Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
RVL Pharmaceuticals plc | General Counsel & Secretary | Ordinary Shares | 181K | $5.63K | $0.03 | May 18, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RVLP | RVL Pharmaceuticals plc | May 18, 2023 | 1 | -$4.74K | 4 | May 22, 2023 | General Counsel & Secretary |
RVLP | RVL Pharmaceuticals plc | Jan 24, 2023 | 1 | -$12.1K | 4 | Jan 26, 2023 | General Counsel & Secretary |
RVLP | RVL Pharmaceuticals plc | May 18, 2022 | 1 | -$8.58K | 4 | May 20, 2022 | General Counsel & Secretary |
RVLP | RVL Pharmaceuticals plc | Jan 24, 2022 | 1 | -$10.9K | 4 | Jan 26, 2022 | General Counsel & Secretary |
RVLP | Osmotica Pharmaceuticals plc | Nov 4, 2021 | 1 | $0 | 4 | Nov 8, 2021 | General Counsel & Secretary |
RVLP | Osmotica Pharmaceuticals plc | May 18, 2021 | 1 | -$20.2K | 4 | May 20, 2021 | General Counsel & Secretary |